Octostim (Desmopressin Acetate)

Desmopressin acetate, the active ingredient in Octostim, is a synthetic vasopressin analog presented as a tablet for oral use. It is employed to manage central diabetes insipidus, nocturnal enuresis in children, and to control bleeding in patients with mild hemophilia A or von Willebrand disease.

GNH USA supplies Octostim as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Desmopressin acetate is used in several endocrine and haemostatic conditions, acting on the vasopressin V2 receptor pathway. - Central Diabetes Insipidus: reduces excessive urine output by concentrating urine. - Nocturnal Enuresis: decreases nighttime bedwetting episodes in children. - Hemophilia A (mild): improves clot formation by raising factor VIII levels. - von Willebrand Disease (type 1): enhances von Willebrand factor release to reduce bleeding.

Desmopressin acetate may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Nasal irritation (if administered intranasally). - Nausea or abdominal discomfort. - Hyponatraemia: mild reduction in serum sodium. - Flushing or warmth sensation.

Serious or Rare Side Effects: - Severe hyponatraemia leading to seizures or coma. - Water intoxication with rapid weight gain. - Allergic reactions such as rash or angioedema. - Thrombotic events in patients with high factor VIII levels. - Cardiac arrhythmias in susceptible individuals.

Desmopressin acetate requires careful monitoring in several clinical situations. - Fluid restriction: limit intake to prevent hyponatraemia. - Renal impairment: adjust use and monitor electrolytes closely. - Cardiovascular disease: watch for fluid overload and blood pressure changes. - Pregnancy and lactation: use only if benefits outweigh risks. - Age considerations: dose may need adjustment in elderly patients. Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Desmopressin acetate can interact with other medicines that affect water balance or coagulation.

Major Interactions (Avoid): - Loop diuretics: increase risk of hyponatraemia. - Antifibrinolytics (e.g., tranexamic acid): may cause excessive clotting. - NSAIDs: potentiate renal effects and fluid retention.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): may contribute to hyponatraemia. - Carbamazepine: can reduce desmopressin efficacy. - Hormonal contraceptives: may alter fluid balance.